MarketInOut Stock Screener Log In | Sign Up

Vivimed Labs Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026
Vivimed Labs Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization506.6 mln
Float50.00 mln

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-5.74
Highly reliable

Relative Strength

48 / 100
In line with market

Pre-Tax Margin

-252%
Severely loss-making

Altman Z-Score

-0.11
Deeply distressed

ROA

-20.38
Deeply negative

Business Description

Founded in 1988 and headquartered in Hyderabad, India, Vivimed Labs Limited is a diversified company operating across two main areas: specialty chemicals and pharmaceuticals. The company produces and sells a range of products including raw pharmaceutical ingredients, finished medicines, and specialty chemicals, serving both domestic and international markets. Its pharmaceutical offerings span several treatment areas, including eye care, skin care, nutrition, and pain relief, along with contract manufacturing services for tablets, capsules, syrups, and other drug forms.

Key Fundamentals

EPS-2.93
RPS13.13
ROIC-18.72
ROA-20.38
EBITDA, mln-1,461
EV / EBITDA-3.02
EV / EBIT-2.56
Revenue, mln700
EV / Revenue6.30

Quote Details

Last 6.11
Change -0.12 (-1.93%)
Open 6.11
Volume 2,655
Turnover 16,222
Average Volume 12,029

Financial Ratios

Pre-Tax Profit Margin-252
Current Ratio0.38
Price / Free Cash Flow17.15
Price / Sales0.64

Financial Strength

Altman Z-Score-0.11
Piotroski F-Score 3 / 9
Beneish M-Score-5.74
Price to Intrinsic Value0.26

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.21% 27 / 100   
1 Month 8.72% 93 / 100   
2 Months 15.07% 87 / 100   
6 Months -20.65% 29 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog